Diabetes and Endocrinology
Home Diabetes and Endocrinology
Text Message Interventions May Help With Weight Management
Interventions classified as effective were more likely to last longer than 12 weeks
Plasma Volume Changes May Mediate Effects of Empagliflozin
Findings suggest reduced CV mortality risk mediated by effects on markers of plasma volume
Pioglitazone Associated With Lower Blood Leptin in Diabetes
In T2DM, leptin levels are lower with pioglitazone than placebo but not oral antidiabetic drugs
CDC: 2015 to 2016 Saw Drop in Life Expectancy in United States
Increase in rate of age-adjusted drug overdose deaths observed during same time period
Bone Fragility Variants Linked to Concordant Pediatric Skeleton
Novel loci identified for discordant multi-dimensional skeletal phenotypes
DPP-4 Inhibitor Has Dissociated Effects on β-Cell Function
Single dose of sitagliptin linked to increases in standardized insulin secretion, active GIP, GLP-1
Intensive BP Goals Reduce Risk of Cardiovascular Events
Benefits similar in patients with and without type 2 diabetes
Pre-Op Liraglutide Cuts Post-Op Plasma Glucose in T2DM
Preoperative administration of liraglutide linked to lower post-op glucose, increase in pre-op nausea
RA Exposure In Utero Tied to Increased Disease Risk
Children exposed to maternal rheumatoid arthritis have higher risk of thyroid disease, epilepsy, RA
Payment for Laboratory Tests Set to Reduce Starting Jan. 1, 2018
CMS Clinical Laboratory Fee Schedule to result in drop in payments for physician office-based tests
